Skip to content
Use caution Drug recall · FDA · Published June 22, 2023

Alembic Diclofenac Topical Solution Recall: Defective Delivery System Risk

Alembic recalls 2% diclofenac topical solution bottles with defective delivery system. This may cause injury during use. Check NDC 62332-487-12 and lots 220151-220153.

🇺🇸 FDA recall #D-0941-2023DrugAlembic ›
Take action

Contact the company

Recalling firmALEMBIC PHARMACEUTICALS, INC.550 Hills Dr Ste 104b · Bedminster, NJ 07921-1537
✎ GovInfoNow plain-language explainer

Alembic is recalling diclofenac sodium topical solution bottles that have a defective delivery system. This could lead to injury if the product is used improperly. Read more at govinfonow.com/recall/33405-alembic-diclofenac-topical-solution-recall-defective-delivery-system-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/33405-alembic-diclofenac-topical-solution-recall-defective-delivery-system-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-0941-2023

Cite this page

“Alembic Diclofenac Topical Solution Recall: Defective Delivery System Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/33405-alembic-diclofenac-topical-solution-recall-defective-delivery-system-risk. Based on FDA recall #D-0941-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0941-2023%22&limit=1).

The FDA announced on June 22, 2023, that Alembic Pharmaceuticals Inc. is recalling Diclofenac Sodium Topical Solution USP due to a defective delivery system. The recall affects 2,844 units distributed nationwide.

How to tell if you have it

  • Brand: Alembic
  • Product: Diclofenac Sodium Topical Solution USP, 2% w/w
  • Size: 3.8 FL.OZ. (112 grams)
  • NDC: 62332-487-12
  • Lot codes: 220151, 220152, 220153
  • Expiration date: 11/2024

The hazard

The product has a defective delivery system. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Alembic Pharmaceuticals Inc. issued another recall on July 27, 2023, for Tobramycin Ophthalmic Solution due to impurities risk. Other recent recalls of similar products include Alembic Fesoterodine Tablets Recall (Dec. 16, 2025) and Sun Pharmaceutical Diclofenac Gel Recall (Jan. 27, 2026).

How to tell if you have this one

Check for NDC code 62332-487-12 and production lots 220151, 220152, or 220153. The product is a 3.8 fl.oz. bottle sold by prescription.

  • Brand
    Alembic
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for NDC 62332-487-12 and production lots 220151, 220152, or 220153 on the bottle.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 41 days after the firm started it.

1. Firm started the recall: Jun 22, 202312. FDA classified it Class II: Jul 24, 202323. Published in FDA’s Enforcement Report: Aug 2, 202332023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The product may have a defective delivery system that could cause leakage or spillage during use, so it's not safe to use as is.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0941-2023 (June 22, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0941-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA